Cancer treatment rarely rests on a single specialist’s judgement alone. The right path forward often depends on weighing surgical options against radiation and systemic therapy, interpreting imaging alongside pathology findings, and considering how these pieces fit together for the individual patient in front of the team. A multidisciplinary tumour board exists precisely for this — bringing every relevant specialty into the same conversation, at the same time, focused on the same case.

Ahead of the discussion, imaging, pathology, and clinical findings are compiled and reviewed by each specialist in advance. During the tumour board itself, surgical oncology, medical oncology, radiation oncology, radiology, and pathology present their perspectives on the case, discuss the treatment options available, and work through the sequencing and combination of therapies most likely to achieve the best outcome. For complex or borderline cases — where the right approach isn’t immediately obvious — this collective discussion is particularly valuable, surfacing considerations that might not emerge from a single consultation.

The outcome of this discussion is a clear, unified treatment recommendation, communicated back to the patient in a follow-up consultation — giving a coordinated plan built on the full weight of specialist input, rather than a single viewpoint.